162 related articles for article (PubMed ID: 31941251)
1. [Advances and unmet needs in clinical studies on liver cirrhosis].
Xu JH; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):913-914. PubMed ID: 31941251
[TBL] [Abstract][Full Text] [Related]
2. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
[TBL] [Abstract][Full Text] [Related]
3. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
[TBL] [Abstract][Full Text] [Related]
4. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
[TBL] [Abstract][Full Text] [Related]
5. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
Garcia-Tsao G; Lim JK;
Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
[TBL] [Abstract][Full Text] [Related]
7. Presentation and complications associated with cirrhosis of the liver.
Poordad FF
Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
[TBL] [Abstract][Full Text] [Related]
8. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
9. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
Gîrleanu I; Trifan A; Stanciu C; Sfarti C
World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
Liu CH; Xing F; Wang J
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
[TBL] [Abstract][Full Text] [Related]
11. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.
Okuda K; Ohnishi K; Kimura K; Matsutani S; Sumida M; Goto N; Musha H; Takashi M; Suzuki N; Shinagawa T
Gastroenterology; 1985 Aug; 89(2):279-86. PubMed ID: 4007419
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension.
Seijo S; Reverter E; Miquel R; Berzigotti A; Abraldes JG; Bosch J; García-Pagán JC
Dig Liver Dis; 2012 Oct; 44(10):855-60. PubMed ID: 22721839
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
14. Cirrhosis of liver and portal vein thrombosis - a review article.
Debnath CR; Debnath MR; Alam MM; Moshwan MM; Alam MJ; Rana MS; Biswas D; Mahmuduzzaman M; Tarafder AJ
Mymensingh Med J; 2014 Jul; 23(3):606-8. PubMed ID: 25178622
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Mesocaval Shunt Creation in a Patient with Chronic Portal and Superior Mesenteric Vein Thrombosis.
Bercu ZL; Sheth SB; Noor A; Lookstein RA; Fischman AM; Nowakowski FS; Kim E; Patel RS
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1316-9. PubMed ID: 25189666
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
17. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol.
Polis S; Fernandez R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):39-51. PubMed ID: 26447006
[TBL] [Abstract][Full Text] [Related]
18. [Role of portal hypertension in the pathogenesis of cirrhotic ascites; its demonstration by portal radiomanometry].
CAROLI J; PARAF A; SCHWARZMANN V
Sem Hop; 1951 Jun; 27(41):1761-76. PubMed ID: 14866288
[No Abstract] [Full Text] [Related]
19. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.
Fernández-Varo G; Oró D; Cable EE; Reichenbach V; Carvajal S; de la Presa BG; Wiśniewski K; Ginés P; Harris G; Jiménez W
Hepatology; 2016 Jan; 63(1):207-16. PubMed ID: 26403564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
